Komori
Treasury Stock4526RIKEN VITAMIN CO.,LTD.Food

Notice Regarding the Status of Share Repurchases

In July 2026, the company acquired 192,500 treasury shares on the Tokyo Stock Exchange for approximately ¥606 million. Cumulative acquisitions under the Board of Directors' resolution totaled 358,300 shares for approximately ¥1.093 billion.

Worth reading
49Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Neutral
Direction inferred from the company’s description.
Scale
192500
Shares
Wording
Definitive
How definitive the wording is.

Progress against acquisition limit

Market purchases on the Tokyo Stock Exchange

Resolved 13 May 2026 / Acquisition period 1 June 2026 to 30 September 2026

39.8%
Cumulative utilization rate
LimitAmount 54.7%541,700 株 remaining
Number of Shares900,000 shares (maximum)
54.7%
Cumulative utilization rate
Limit906,729,013 円 remaining
Amount¥2,000,000,000 (maximum)

The darker band is the portion acquired this time (1 July 2026–31 July 2026). At this pace, the monetary limit will be reached first, and the acquisition will end without using the full share-count limit.

Number of Shares
Limit900,000 shares (maximum)
Cumulative total358,300 shares (as of 31 July 2026)
Current192,500 shares
Amount
Limit¥2,000,000,000 (maximum)
Cumulative total¥1,093,270,987 (as of 31 July 2026)
Current¥606,175,989
Percentage of total issued shares3.08% (as a percentage of the total number of issued shares excluding treasury shares)
Average acquisition price for this transaction (calculated)¥3,149 per shareCurrent acquisition price ÷ current number of shares acquired

消化率と残りは、会社が示した累計・今回と上限から算出しています。進捗率=上限に対してどこまで使ったかの割合です。

Progress against acquisition limit
ItemDetails
Total number of shares acquired in this transaction192,500 shares
Total current acquisition price¥606,175,989
Acquisition date/acquisition period1 July 2026–31 July 2026
Method of acquisitionMarket purchases on the Tokyo Stock Exchange
Cumulative number of shares acquired358,300 shares (as of 31 July 2026)
Cumulative acquisition cost¥1,093,270,987 (as of 31 July 2026)
Resolution date13 May 2026
Maximum number of shares to be acquired900,000 shares (maximum)
Total acquisition price¥2,000,000,000 (maximum)
Acquisition period under the resolution1 June 2026 to 30 September 2026
Percentage of total issued shares3.08% (as a percentage of the total number of issued shares excluding treasury shares)
Items this document does not state (2)
Whether acquisition has been completedAverage Acquisition Price

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The reason for the purchases is not stated in this document.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding the Status of Share Repurchases | RIKEN VITAMIN CO.,LTD. (4526) timely disclosure | Komori